MOONLAKE IMMUNOTHERAPEUTICS (MLTX)

KY61559X1045 - Common Stock

52.17  +0.29 (+0.56%)

After market: 52.17 0 (0%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to MLTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 75.4. This target is 44.53% above the current price.
MLTX was analyzed by 23 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about MLTX.
In the previous month the buy percentage consensus was at a similar level.
MLTX was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 52.1755.5573.4475.40109.20 - 6.48% 40.77% 44.53% 109.32%
Up and Down Grades
Date Firm Action Rating
2024-11-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-23 Cantor Fitzgerald Reiterate Overweight
2024-09-12 Needham Reiterate Buy -> Buy
2024-09-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-09 Cantor Fitzgerald Reiterate Overweight
2024-08-26 Wolfe Research Downgrade Outperform -> Peer Perform
2024-08-08 Needham Maintains Buy -> Buy
2024-07-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-25 Oppenheimer Initiate Outperform
2024-06-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-10 Needham Reiterate Buy -> Buy
2024-05-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-08 Needham Reiterate Buy -> Buy
2024-05-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-23 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-09 Needham Reiterate Buy -> Buy
2024-04-02 Goldman Sachs Initiate Neutral
2024-03-13 Wedbush Reiterate Outperform -> Outperform
2024-03-11 Needham Reiterate Buy -> Buy
2024-03-11 Wedbush Reiterate Outperform -> Outperform
2024-03-11 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-04 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-01 Needham Reiterate Buy -> Buy
2024-03-01 Wedbush Reiterate Outperform -> Outperform
2024-02-15 Wolfe Research Initiate Outperform
2023-12-18 Stifel Maintains Buy -> Buy
2023-12-08 Citigroup Initiate Buy